92 related articles for article (PubMed ID: 23719583)
1. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
Kerns SL; Stock RG; Stone NN; Blacksburg SR; Rath L; Vega A; Fachal L; Gómez-Caamaño A; De Ruysscher D; Lammering G; Parliament M; Blackshaw M; Sia M; Cesaretti J; Terk M; Hixson R; Rosenstein BS; Ostrer H
Radiother Oncol; 2013 Jun; 107(3):372-6. PubMed ID: 23719583
[TBL] [Abstract][Full Text] [Related]
2. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
Ahmed M; Dorling L; Kerns S; Fachal L; Elliott R; Partliament M; Rosenstein BS; Vega A; Gómez-Caamaño A; Barnett G; Dearnaley DP; Hall E; Sydes M; Burnet N; Pharoah PD; Eeles R; West CM
Br J Cancer; 2016 May; 114(10):1165-74. PubMed ID: 27070714
[TBL] [Abstract][Full Text] [Related]
3. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.
Oh JH; Lee S; Thor M; Rosenstein BS; Tannenbaum A; Kerns S; Deasy JO
Radiother Oncol; 2023 Aug; 185():109723. PubMed ID: 37244355
[TBL] [Abstract][Full Text] [Related]
4. KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through Circular RNA-Mediated KDM3B Expression and Inflammatory Responses.
Sun Y; Tsai Y; Wood R; Shen B; Chen J; Zhou Z; Zeng G; Marples B; Kerns S; Chen Y
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):251-260. PubMed ID: 38008196
[TBL] [Abstract][Full Text] [Related]
5. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
Fachal L; Gómez-Caamaño A; Barnett GC; Peleteiro P; Carballo AM; Calvo-Crespo P; Kerns SL; Sánchez-García M; Lobato-Busto R; Dorling L; Elliott RM; Dearnaley DP; Sydes MR; Hall E; Burnet NG; Carracedo Á; Rosenstein BS; West CM; Dunning AM; Vega A
Nat Genet; 2014 Aug; 46(8):891-4. PubMed ID: 24974847
[TBL] [Abstract][Full Text] [Related]
6. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
[TBL] [Abstract][Full Text] [Related]
7. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.
Kerns SL; Ostrer H; Rosenstein BS
Cancer Discov; 2014 Feb; 4(2):155-65. PubMed ID: 24441285
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomics: the search for genetic predictors of radiotherapy response.
Kerns SL; West CM; Andreassen CN; Barnett GC; Bentzen SM; Burnet NG; Dekker A; De Ruysscher D; Dunning A; Parliament M; Talbot C; Vega A; Rosenstein BS
Future Oncol; 2014 Dec; 10(15):2391-406. PubMed ID: 25525847
[TBL] [Abstract][Full Text] [Related]
9. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
10. STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.
Kerns SL; de Ruysscher D; Andreassen CN; Azria D; Barnett GC; Chang-Claude J; Davidson S; Deasy JO; Dunning AM; Ostrer H; Rosenstein BS; West CM; Bentzen SM
Radiother Oncol; 2014 Jan; 110(1):182-8. PubMed ID: 23993398
[TBL] [Abstract][Full Text] [Related]
11. Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy.
Kerns SL; Fachal L; Dorling L; Barnett GC; Baran A; Peterson DR; Hollenberg M; Hao K; Narzo AD; Ahsen ME; Pandey G; Bentzen SM; Janelsins M; Elliott RM; Pharoah PDP; Burnet NG; Dearnaley DP; Gulliford SL; Hall E; Sydes MR; Aguado-Barrera ME; Gómez-Caamaño A; Carballo AM; Peleteiro P; Lobato-Busto R; Stock R; Stone NN; Ostrer H; Usmani N; Singhal S; Tsuji H; Imai T; Saito S; Eeles R; DeRuyck K; Parliament M; Dunning AM; Vega A; Rosenstein BS; West CML
J Natl Cancer Inst; 2020 Feb; 112(2):179-190. PubMed ID: 31095341
[TBL] [Abstract][Full Text] [Related]
12. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Håkansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Beane Freeman LE; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA; ; ; ; ; ; ; ; ;
Nat Genet; 2018 Jul; 50(7):928-936. PubMed ID: 29892016
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of prostate cancer-specific survival.
Szulkin R; Karlsson R; Whitington T; Aly M; Gronberg H; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; FitzGerald LM; Henderson BE; Schumacher FR; Haiman CA; Sipeky C; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah PD; Pashayan N; Khaw KT; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubiński J; Kluźniak W; Cannon-Albright L; Brenner H; Herrmann V; Holleczek B; Park JY; Sellers TA; Lim HY; Slavov C; Kaneva RP; Mitev VI; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; ; Batra J; Clements JA; ; Albanes D; Andriole GL; Berndt SI; Chanock S; Gapstur SM; Giovannucci EL; Hunter DJ; Kraft P; Le Marchand L; Ma J; Mondul AM; Penney KL; Stampfer MJ; Stevens VL; Weinstein SJ; Trichopoulou A; Bueno-de-Mesquita BH; Tjønneland A; Cox DG; ; Maehle L; Schleutker J; Lindström S; Wiklund F
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1796-800. PubMed ID: 26307654
[TBL] [Abstract][Full Text] [Related]
15. Two susceptibility loci identified for prostate cancer aggressiveness.
Berndt SI; Wang Z; Yeager M; Alavanja MC; Albanes D; Amundadottir L; Andriole G; Beane Freeman L; Campa D; Cancel-Tassin G; Canzian F; Cornu JN; Cussenot O; Diver WR; Gapstur SM; Grönberg H; Haiman CA; Henderson B; Hutchinson A; Hunter DJ; Key TJ; Kolb S; Koutros S; Kraft P; Le Marchand L; Lindström S; Machiela MJ; Ostrander EA; Riboli E; Schumacher F; Siddiq A; Stanford JL; Stevens VL; Travis RC; Tsilidis KK; Virtamo J; Weinstein S; Wilkund F; Xu J; Lilly Zheng S; Yu K; Wheeler W; Zhang H; ; Sampson J; Black A; Jacobs K; Hoover RN; Tucker M; Chanock SJ
Nat Commun; 2015 May; 6():6889. PubMed ID: 25939597
[TBL] [Abstract][Full Text] [Related]
16. Moving the Needle Forward in Genomically-Guided Precision Radiation Treatment.
Tam A; Mercier BD; Thomas RM; Tizpa E; Wong IG; Shi J; Garg R; Hampel H; Gray SW; Williams T; Bazan JG; Li YR
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001574
[TBL] [Abstract][Full Text] [Related]
17. Multivariate piecewise linear regression model to predict radiosensitivity using the association with the genome-wide copy number variation.
Tobiasz J; Al-Harbi N; Bin Judia S; Majid Wakil S; Polanska J; Alsbeih G
Front Oncol; 2023; 13():1154222. PubMed ID: 37849808
[TBL] [Abstract][Full Text] [Related]
18. Low dose ionizing radiation effects on the immune system.
Lumniczky K; Impens N; Armengol G; Candéias S; Georgakilas AG; Hornhardt S; Martin OA; Rödel F; Schaue D
Environ Int; 2021 Apr; 149():106212. PubMed ID: 33293042
[TBL] [Abstract][Full Text] [Related]
19. Harnessing genome-wide association studies to minimize adverse radiation-induced side effects.
Benitez CM; Knox SJ
Radiat Oncol J; 2020 Dec; 38(4):226-235. PubMed ID: 33233031
[TBL] [Abstract][Full Text] [Related]
20. The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
Simões AR; Fernández-Rozadilla C; Maroñas O; Carracedo Á
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33228198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
